The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2R)-N-[(3R)-8-cyclobutoxy-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]-5,5,5-trifluoro-2-[2-oxo-2-(piperidin-1-yl)ethyl]pentanamide ID: ALA5283923
Max Phase: Preclinical
Molecular Formula: C32H37F3N4O4
Molecular Weight: 598.67
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CN1C(=O)[C@H](NC(=O)[C@H](CCC(F)(F)F)CC(=O)N2CCCCC2)N=C(c2ccccc2)c2ccc(OC3CCC3)cc21
Standard InChI: InChI=1S/C32H37F3N4O4/c1-38-26-20-24(43-23-11-8-12-23)13-14-25(26)28(21-9-4-2-5-10-21)36-29(31(38)42)37-30(41)22(15-16-32(33,34)35)19-27(40)39-17-6-3-7-18-39/h2,4-5,9-10,13-14,20,22-23,29H,3,6-8,11-12,15-19H2,1H3,(H,37,41)/t22-,29+/m1/s1
Standard InChI Key: BWUPONRZUQMQRG-MNNSJKJDSA-N
Molfile:
RDKit 2D
43 47 0 0 0 0 0 0 0 0999 V2000
-2.1656 0.6938 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4515 0.2807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4515 -0.5465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1637 -0.9593 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7953 -1.0633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0129 -0.8724 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.3677 -0.1240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0007 0.6235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8073 0.8002 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0213 1.5998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5844 1.2088 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.1952 -0.1240 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.6088 0.5924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4365 0.5924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8504 1.3092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6781 1.3092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0918 2.0260 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.0918 0.5924 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.8502 -0.1240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4365 -0.8406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8502 -1.5574 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1952 1.3092 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.0095 -1.8629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4244 -2.4483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6386 -3.2452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4385 -3.4594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0220 -2.8783 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8125 -2.0780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4363 -2.2739 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.6777 -1.5574 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.0644 -2.3567 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-2.8824 0.2804 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8824 -0.5502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5990 0.6943 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.3157 0.2804 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6780 2.7427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0917 3.4594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9192 3.4594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3331 2.7428 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9193 2.0261 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.5336 -0.5324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.3331 -0.3182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1152 0.4947 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 2 0
4 3 1 0
3 5 1 0
5 6 2 0
7 6 1 0
8 7 1 0
2 9 1 0
9 8 1 0
9 10 1 0
8 11 2 0
7 12 1 6
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
16 18 2 0
14 19 1 1
19 20 1 0
20 21 1 0
13 22 2 0
5 23 1 0
24 23 2 0
25 24 1 0
26 25 2 0
27 26 1 0
28 27 2 0
23 28 1 0
21 29 1 0
21 30 1 0
21 31 1 0
1 32 2 0
32 33 1 0
33 4 2 0
32 34 1 0
34 35 1 0
36 17 1 0
37 36 1 0
38 37 1 0
39 38 1 0
40 39 1 0
17 40 1 0
41 35 1 0
42 41 1 0
42 43 1 0
43 35 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 598.67Molecular Weight (Monoisotopic): 598.2767AlogP: 5.24#Rotatable Bonds: 9Polar Surface Area: 91.31Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: 11.20CX Basic pKa: 0.59CX LogP: 4.59CX LogD: 4.59Aromatic Rings: 2Heavy Atoms: 43QED Weighted: 0.43Np Likeness Score: -0.19
References 1. Lee S, Love MS, Modukuri R, Chatterjee AK, Huerta L, Lawson AP, McNamara CW, Mead JR, Hedstrom L, Cuny GD.. (2023) Structure-activity relationship of BMS906024 derivatives for Cryptosporidium parvum growth inhibition., 90 [PMID:37196868 ] [10.1016/j.bmcl.2023.129328 ]